BNP Paribas Bonus Zert PFE 30.12..../ DE000PN7MYR9 /

24/05/2024 21:40:18	Chg.-0.110	Bid21:59:08	Ask-	Underlying	Strike price	Expiration date	Option type
31.600EUR	-0.35%	31.710 Bid Size: 2,500	- Ask Size: -	Pfizer Inc	- USD	30/12/2024	Call

GlobeNewswire 16/05 Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combinatio...

TeleTrader 01/05 Pfizer's Q1 revenue drops 20% to $14.9 billion

GlobeNewswire 30/04 TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervica...

GlobeNewswire 22/03 Gastroenterologists Slow to Adopt Eli Lilly’s Omvoh, Pfizer’s Velsipity, and Takeda’s subcutaneous ...

GlobeNewswire 20/03 Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook

GlobeNewswire 07/03 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...

GlobeNewswire 07/03 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 05/03 LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd...

GlobeNewswire 28/02 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 28/02 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...

GlobeNewswire 27/02 Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin as a New Treatment t...

GlobeNewswire 23/02 Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market

GlobeNewswire 20/02 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 16/02 ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Befo...

GlobeNewswire 11/02 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 08/02 ROSEN, A RANKED AND LEADING FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Importan...

GlobeNewswire 06/02 Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment o...

GlobeNewswire 03/02 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

TeleTrader 30/01 Pfizer posts Q4 revenue of $14B, reaffirms guidance

GlobeNewswire 26/01 ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadl...

GlobeNewswire 26/01 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 18/01 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 21/12/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...

GlobeNewswire 19/12/2023 Related Sciences Adds 8 New Senior Advisors Including Former CEOs and Heads of R&D from Genentech, N...

GlobeNewswire 13/12/2023 Arch Biopartners Submits Application to Health Canada to Conduct the Phase II Cardiac Surgery Associ...